Valuation: Danaher Corporation

Market Cap 161B 814B 144B 133B 121B 227B 15,265B 231B 1,595B 627B 7,979B 604B 591B 25,506B P/E 2026 *
39x
P/E 2027 * 31.5x
Enterprise Value 182B 918B 162B 150B 136B 256B 17,216B 260B 1,798B 707B 8,998B 681B 667B 28,764B EV / Sales 2026 *
6.89x
EV / Sales 2027 * 6.22x
Free-Float
70.56%
Yield 2026 *
0.63%
Yield 2027 * 0.68%
1 day-5.07%
1 week-0.40%
Current month-1.18%
1 month+2.76%
3 months+9.71%
6 months+16.30%
Current year-11.07%
1 week 39.84
Extreme 39.84
42.39
1 month 38
Extreme 38
42.39
Current year 28.02
Extreme 28.02
46
1 year 28.02
Extreme 28.02
46.06
3 years 28.02
Extreme 28.02
57.37
5 years 28.02
Extreme 28.02
66.27
10 years 8.86
Extreme 8.858775
66.27
Manager TitleAgeSince
Chief Executive Officer - 2026-09-30
Director of Finance/CFO - 2026-02-27
Chief Tech/Sci/R&D Officer - 2025-08-24
Director TitleAgeSince
Director/Board Member 74 1999-06-30
Chairman 74 1983-12-31
Director/Board Member 69 1983-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-5.07%-0.40% - - 161B
-1.54%+3.25%+26.06%+45.40% 255B
-2.01%+2.10%+7.35%+9.58% 161B
+1.52%+2.17%-2.90%+57.22% 151B
+1.49%+5.43%-54.60%-11.16% 64.33B
-1.01%+4.83%-14.13%-13.29% 51.9B
+2.08%+6.98%+11.66%+53.64% 50.25B
+0.72%+2.36%+16.85%+25.12% 49.92B
-1.77%-0.38%+19.72%+56.43% 48.77B
-0.61%+0.12%+29.79%+74.75% 42.93B
Average -0.81%+3.12%+4.42%+33.08% 97.22B
Weighted average by Cap. -1.32%+3.42%+7.79%+34.58%

Financials

2026 *2027 *
Net sales 26.35B 133B 23.49B 21.76B 19.78B 37.13B 2,498B 37.74B 261B 103B 1,306B 98.87B 96.8B 4,174B 28.48B 144B 25.39B 23.52B 21.39B 40.13B 2,701B 40.79B 282B 111B 1,411B 107B 105B 4,512B
Net income 4.18B 21.13B 3.73B 3.45B 3.14B 5.89B 396B 5.98B 41.39B 16.28B 207B 15.68B 15.35B 662B 5.18B 26.18B 4.62B 4.28B 3.89B 7.29B 491B 7.41B 51.28B 20.17B 257B 19.43B 19.02B 820B
Net Debt 20.57B 104B 18.34B 16.99B 15.44B 28.98B 1,950B 29.46B 204B 80.11B 1,019B 77.18B 75.56B 3,259B 16.17B 81.77B 14.42B 13.35B 12.14B 22.79B 1,533B 23.16B 160B 62.99B 801B 60.68B 59.41B 2,562B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
26-10-19 R$40.24 -5.07% 5,931
26-10-16 R$42.39 +0.83% 17
26-10-15 R$42.04 +4.06% 2,157
26-10-13 R$40.40 +2.64% 123
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
229.04USD
Average target price
244.14USD
Spread / Average Target
+6.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Danaher Corporation